首页> 美国卫生研究院文献>Nutrients >Chrysanthemum Leaf Ethanol Extract Prevents Obesity and Metabolic Disease in Diet-Induced Obese Mice via Lipid Mobilization in White Adipose Tissue
【2h】

Chrysanthemum Leaf Ethanol Extract Prevents Obesity and Metabolic Disease in Diet-Induced Obese Mice via Lipid Mobilization in White Adipose Tissue

机译:菊花叶乙醇提取物通过白色脂肪组织中的脂质动员预防饮食诱导的肥胖小鼠的肥胖和代谢性疾病

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This study aimed to elucidate the molecular mechanism of Chrysanthemum morifolium Ramat. against obesity and diabetes, by comparing the transcriptional changes in epididymal white adipose tissue (eWAT) with those of the bioactive compound in C. morifolium, luteolin (LU). Male C57BL/6J mice were fed a normal diet, high-fat diet (HFD), and HFD supplemented with 1.5% w/w chrysanthemum leaf ethanol extract (CLE) for 16 weeks. Supplementation with CLE and LU significantly decreased the body weight gain and eWAT weight by stimulating mRNA expressions for thermogenesis and energy expenditure in eWAT via lipid mobilization, which may be linked to the attenuation of dyslipidemia. Furthermore, CLE and LU increased uncoupling protein-1 protein expression in brown adipose tissue, leading to energy expenditure. Of note, CLE and LU supplements enhanced the balance between lipid storage and mobilization in white adipose tissue (WAT), in turn, inhibiting adipocyte inflammation and lipotoxicity of peripheral tissues. Moreover, CLE and LU attenuated hepatic steatosis by suppressing hepatic lipogenesis, thereby ameliorating insulin resistance and dyslipidemia. Our data suggest that CLE helps inhibit obesity and its comorbidities via the complex interplay between liver and WAT in diet-induced obese mice.
机译:这项研究旨在阐明菊花拉玛特的分子机制。通过比较附睾白色脂肪组织(eWAT)和生物活性化合物在mo叶木犀草素(LU)中的转录变化来对抗肥胖和糖尿病。给雄性C57BL / 6J小鼠喂食正常饮食,高脂饮食(HFD)和补充1.5%w / w菊花叶乙醇提取物(CLE)的HFD,持续16周。补充CLE和LU可通过脂质动员刺激mRNA表达以促进eWAT的生热和能量消耗,从而显着降低体重增加和eWAT体重,这可能与血脂异常的减轻有关。此外,CLE和LU增加了棕色脂肪组织中非偶联蛋白1蛋白的表达,从而导致能量消耗。值得注意的是,CLE和LU补充剂增强了白色脂肪组织(WAT)中脂质存储和动员之间的平衡,进而抑制了脂肪细胞的炎症和周围组织的脂毒性。此外,CLE和LU通过抑制肝脏脂肪生成来减轻肝脏脂肪变性,从而改善胰岛素抵抗和血脂异常。我们的数据表明,CLE通过饮食诱导的肥胖小鼠中肝脏和WAT之间的复杂相互作用,有助于抑制肥胖及其合并症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号